About: Clinical Features of COVID-19 Related Liver Damage

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Clinical Features of COVID-19 Related Liver Damage Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Clinical Features of COVID-19 Related Liver Damage
Creator	Li, Jun Chen, Liping Cheng, Jilin Fan, Zhenyu Huang, Shaoping Liu, Zhanju Tian, Cheng Zhang, Yajun
Source	MedRxiv
abstract	BACKGROUND: A recent outbreak of SARS-CoV-2 infection occurs mainly in China, with rapidly increasing the number of cases (namely COVID-19). Abnormal liver functions are frequently present in these patients, here we aimed to clarify the clinical features of COVID-19-related liver damage to provide some references for the clinical treatment. METHODS: In this retrospective, single-center study, we included all confirmed COVID-19 cases in Shanghai Public Health Clinical Center from January 20 to January 31, 2020. The outcomes were followed up until February 19, 2020. A total of 148 cases were analyzed for clinical features, laboratory parameters (including liver function tests), medications and the length of stay. FINDINGS: Of 148 confirmed SARS-CoV-2-infected patients, 49.3% were females and 50.7% were males. The median age was 50.5 years (interquartile range, 36-64). Patients had clinical manifestations of fever (70.1%), cough (45.3%), expectoration (26.7%) at admission. 75 patients (50.7%) showed abnormal liver functions at admission, characterized by an increased of alt, ast, GGT, AKP. Patients (n = 75) who had elevated liver function index were more likely to have a moderate-high degree fever (44% vs 27.4%; p = 0.035) and significantly present in male patients (62.67% vs 38.36%; p = 0.005). The numbers of CD4+ and CD8+ T cells were significantly lower in abnormal liver function group than those in normal liver function group. There was no statistical difference in prehospital medications between normal and abnormal liver function groups, while the utilization rate of lopinavir/ritonavir after admission was significantly higher in patients with emerging liver injury than that in patients with normal liver functions. Importantly, the emerging abnormal liver functions after admission caused a prolonged length of stay. INTERPRETATION: SARS-CoV-2 may cause the liver function damage and the Lopinavir/ritonavir should be applied carefully for the treatment of COVID-19.
has issue date	2020-02-27(xsd:dateTime)
bibo:doi	10.1101/2020.02.26.20026971
has license	medrxiv
sha1sum (hex)	64f1fe510cb6bc6811eabac70095c7805aac35df
schema:url	https://doi.org/10.1101/2020.02.26.20026971
resource representing a document's title	Clinical Features of COVID-19 Related Liver Damage
resource representing a document's body	covid:64f1fe510cb6bc6811eabac70095c7805aac35df#body_text
is schema:about of	named entity 'provide' named entity 'patients' named entity 'COVID' named entity 'China' named entity 'liver' named entity 'clinical features' named entity 'clinical treatment' named entity 'liver damage' named entity 'Clinical Features' named entity 'COVID-19' covid:arg/64f1fe510cb6bc6811eabac70095c7805aac35df named entity 'Liver Damage' named entity 'clarify' named entity 'liver damage' named entity 'China' named entity 'COVID-19' named entity 'rapidly' named entity 'frequently' named entity 'references' named entity 'cases' named entity 'clinical treatment' named entity 'Damage' named entity 'functions' named entity 'Abnormal' named entity 'Liver' named entity 'Related' named entity 'Features' named entity 'COVID-19' nodeID://b56409866 nodeID://b56457070 nodeID://b56494966 nodeID://b56601598 nodeID://b56625266 nodeID://b56633298 nodeID://b56634426 nodeID://b56671322 nodeID://b56736566 nodeID://b56760410 nodeID://b56787826 nodeID://b56802210 nodeID://b56842566 nodeID://b56860974 nodeID://b56892798 nodeID://b57010854 nodeID://b57048054 nodeID://b57084910 nodeID://b57129258 nodeID://b57165542 nodeID://b57169062 nodeID://b57206646 nodeID://b57325334 nodeID://b57346042 nodeID://b57399790 nodeID://b57598898 nodeID://b57613546 nodeID://b57614502 nodeID://b57638822 nodeID://b57638870 nodeID://b57701558 nodeID://b57725330 nodeID://b57733902 nodeID://b57817498 nodeID://b57928430 nodeID://b57978474 nodeID://b57991966 nodeID://b58075002
is wasQuotedFrom of	covid:arg/64f1fe510cb6bc6811eabac70095c7805aac35df/2 covid:arg/64f1fe510cb6bc6811eabac70095c7805aac35df/1 covid:arg/64f1fe510cb6bc6811eabac70095c7805aac35df/0
is part of of	covid:64f1fe510cb6bc6811eabac70095c7805aac35df#body_text Clinical Features of COVID-19 Related Liver Damage BACKGROUND: A recent outbreak of SARS-CoV-2 infection occurs mainly in China, with rapidly increasing the number of cases (namely COVID-19). Abnormal liver functions are frequently present in these patients, here we aimed to clarify the clinical features of COVID-19-related liver damage to provide some references for the clinical treatment. METHODS: In this retrospective, single-center study, we included all confirmed COVID-19 cases in Shanghai Public Health Clinical Center from January 20 to January 31, 2020. The outcomes were followed up until February 19, 2020. A total of 148 cases were analyzed for clinical features, laboratory parameters (including liver function tests), medications and the length of stay. FINDINGS: Of 148 confirmed SARS-CoV-2-infected patients, 49.3% were females and 50.7% were males. The median age was 50.5 years (interquartile range, 36-64). Patients had clinical manifestations of fever (70.1%), cough (45.3%), expectoration (26.7%) at admission. 75 patients (50.7%) showed abnormal liver functions at admission, characterized by an increased of alt, ast, GGT, AKP. Patients (n = 75) who had elevated liver function index were more likely to have a moderate-high degree fever (44% vs 27.4%; p = 0.035) and significantly present in male patients (62.67% vs 38.36%; p = 0.005). The numbers of CD4+ and CD8+ T cells were significantly lower in abnormal liver function group than those in normal liver function group. There was no statistical difference in prehospital medications between normal and abnormal liver function groups, while the utilization rate of lopinavir/ritonavir after admission was significantly higher in patients with emerging liver injury than that in patients with normal liver functions. Importantly, the emerging abnormal liver functions after admission caused a prolonged length of stay. INTERPRETATION: SARS-CoV-2 may cause the liver function damage and the Lopinavir/ritonavir should be applied carefully for the treatment of COVID-19.

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software